Coronavirus Update: To New & Existing Clients Learn More ›

Articles Posted in Dangerous Drugs

Many heartburn sufferers have relied on Zantac and other generic ranitidine-containing brands to relieve the burning sensation typically caused by gastroesophageal reflux (GERD). When recent studies linked the over-the-counter (OTC) ranitidine drug to various forms of stomach cancer, the government pulled Zantac from retail shelves in the United States.

Were you diagnosed with Zantac OTC-related cancer, or did you lose a loved one from wrongful death? The personal injury attorneys at Rosenfeld Injury Lawyers, LLC can serve as your legal advocate to help you seek justice and the financial compensation you deserve.

Contact our Zantac cancer attorneys today at (888) 424-5757 (toll-free phone call) or through the contact form to schedule a free consultation. All information you share with our law offices remains confidential through an attorney-client relationship.

The United States Food and Drug Administration FDA Puts Out Warning for Ranitidine Users

In early April 2020, the U.S. Food and Drug Administration FDA warned that the over the counter heartburn medication Zantac ranitidine was unsafe. The FDA said this because all ranitidine products contain unacceptable levels of NDMA (N Nitrosodimethylamine NDMA).

When N Nitrosodimethylamine NDMA breaks down, ranitidine drugs can lead to cancer or probable human carcinogen if the levels of NDMA build up too much so you should talk to a health care professional about prescriptions and the FDA recall.

Find Out How Long You Have to File a Case for Your Injuries

Ever since the U.S. Food and Drug Administration said there might be health problems associated with Zantac and any ranitidine product, people started to consider filing Zantac cases cases and a Zantac lawsuit.

The essential thrust of any Zantac cancer trials and Zantac lawsuits is that the N Nitrosodimethylamine NDMA in Zantac (a popular heartburn drug sold over the counter) might give you cancer after taking it.

Find Out if You Can Bring a Zantac Lawsuit or Join a Ranitidine Class Action Lawsuit

In April 2020, the Food and Drug Administration (FDA) warned that the popular heartburn medication, Zantac (ranitidine), should not be taken because of high levels of NDMA (N Nitrosodimethylamine NDMA) in Zantac medication. Ranitidine tablets are primarily taken for acid reflux, GERD, heartburn and other problems.

Now, people who bought it off retail shelves are concerned it could could cause cancer (including a cancer diagnosis of stomach cancer, kidney cancer, prostate cancer, bladder cancer, brain cancer, or other side effects) due to high NDMA levels in the over the counter Zantac and its generic ranitidine alternative.

Many People are Considering a Zantac Cancer Lawsuit Because of NDMA Concentration

The U.S. Food and Drug Administration FDA put out a warning in April 2020 regarding the popular heartburn medication Zantac ranitidine because it contains N Nitrosodimethylamine (NDMA). High levels of NDMA could lead to cancer including stomach cancer, bladder cancer breast cancer, kidney cancer, and prostate cancer among others.

The heartburn drug Zantac and ranitidine medications is supposed to fix stomach acid, gastroesophageal reflux disease (GERD), but it may cause cancer per the FDA drug warning.

Janet Woodcock and the Food and Drug Administration (FDA) Make Pronouncement on Zantac and Ranitidine Products

The United States Food and Drug Administration (FDA), led by Janet Woodcock, recently recommended the removal of any drug on the market that contain ranitidine or ranitidine products, circa April 1 2020. Many heartburn medications (also called H2 blockers) like Zantac have ranitidine in them.

In fact, ranitidine is the medical term for Zantac. Zantac is an over the counter drug meant to treat GERD, heartburn, acid reflux, and other side effects. These ranitidine medications and all ranitidine products or ranitidine drugs (including otc ranitidine) have NDMA in them and ranitidine products increases the chances of cancer if the NDMA is at unacceptable levels per FDA warning.

Food and Drug Administration Warns against Zantac Usage

The United States Food and Drug Administration (FDA) announced a warning regarding taking Zantac in April of 2020. This is the brand name for ranitidine.

Ranitidine products are H2 blockers that limit acid reflux, stomach acid, heartburn symptoms, gastroesophageal reflux disease (GERD),and other stomach problems.

Financial Compensation for Zantac Cancer Lawsuits

Many individuals and families who have been impacted by Zantac and ranitidine medications are now asking about the compensation available by pursuing a Zantac cancer lawsuit. From the start, at the time of this writing– there is no settlement of any pending lawsuits involving Zantac or ranitidine (generic Zantac).

The cases are still early on the the litigation phases and there are no trial dates set or anticipated settlements forthcoming.

What Type of Cancers Are Associated Zantac Products?

You may have heard of Zantac. It is also referred to by its medical term, Ranitidine. A lot of people took it for stomach and intestinal issues including ulcers, acid reflux, stomach acid, peptic ulcer disease.

You may have also heard that small amounts of levels of NDMA (N Nitrosodimethylamine NDMA) were found last year in ranitidine products by the FDA (Food and Drug Administration).

EPA and What they are doing about Ethylene Oxide EmissionsAt the end of 2019, the U.S. EPA (Environmental Protection Agency) proposed amending the current control measure regulations involving Ethylene Oxide (ETO) emission standards for commercial sterilization facilities.

The hazardous chemicals amendment would help reduce the cancer-causing ETO toxic chemical emissions and other toxic substances at facilities emitting higher concentrations.

The increased risk can result in adverse health effects due to short and long-term human exposure to the harmful chemical at or nearby commercial sterilization facilities.